Transforming Health Care Through Evidence and Collaboration
Transforming Health Care Through Evidence and Collaboration
The NIHCM Foundation is a nonprofit, nonpartisan organization dedicated to improving the effectiveness, efficiency and quality of America's health care system.
  • Advisory Board

    NIHCM Foundation is pleased to welcome Dr. Scott Gottlieb, Sherry Glied, PhD, and Katherine Baicker, PhD, to its distinguished Advisory Board. Their ideas and insights will advance NIHCM's mission to improve health care for millions of Americans.

    Press Release Advisory Board
  • Awards

    NIHCM Foundation hosted the 25th Annual NIHCM Awards at the Organization of American States in Washington, D.C. to recognize outstanding health care research and journalism.

    Press Release Winners Finalists
  • News

    NIHCM welcomed Secretary Azar to a meeting in March to discuss efforts by the Department of Health and Human Services to transform health care by lowering costs and improving value for patients.

  • Webinars

    As recognition of our country's mental and behavioral health challenges grows, Americans are looking for answers that will increase their happiness and well-being and prevent deaths of despair related to mental health, opioids and suicide. Our four-part webinar series delves into the research and explores innovative strategies and evidence-based solutions to lift our society from crisis.

    Learn More
  • Grants

    NIHCM Foundation has awarded ten grants for health care journalism including investigative reporting, public engagement campaigns for documentaries and educational opportunities for reporters.

    Press Release All Journalism Grantees Apply for Funding
  • Grants

    NIHCM has awarded over $400,000 in grants to support seven investigator-initiated research studies on topics including value-based drug pricing and Medicaid expansion.

    Press Release All Research Grantees Apply for Funding
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

Events

June 13, 2019
opioids-2019-webinar-graphic

The final part in our four-part Defying Despair series, this webinar discussed ongoing efforts to increase access to evidence-based treatment for opioid use disorder and guide people on a path to recovery.

May 16, 2019
Alliance-Rx-Patent-Webinar-052019

Manufacturer practices under the current patent system have come under scrutiny for blocking or delaying the entry of generic or biosimilar drugs into the market. During this webinar, panelists explored the relationship between patents, prices and patient access.

In the News

July 2019
Population Health Spotlight
ALZ-panel1-June2019

How Much Diagnostic Imaging Is Inappropriate and What Does It Cost?

Why This Study Is Important

Overall utilization of diagnostic imaging procedures has been increasing rapidly in the U.S., and we now spend well over $100 billion on these procedures each year. At the same time, evidence is mounting that a nontrivial portion of this care is provided inappropriately, conferring little value to patients and perhaps causing harm. This study expands that evidence base by examining the extent of inappropriate diagnostic imaging for three common conditions within a large group of commercially insured adults in Massachusetts.

What This Study Found

  • For all three conditions, the percent of X-rays and MRIs provided within 30 days of the initial visit increased between 2010 and 2013.
  • More than 60 percent of lumbar spine MRIs and approximately 40 percent of lumbar spine X-rays received in the 30 days after the visit were deemed inappropriate in both 2010 and 2013. For knee and shoulder pain, more than 30 percent of the MRIs were inappropriate in both years. Similar results were obtained using a 60-day window.
  • Compared to patients for whom MRI imaging was appropriate, patients receiving inappropriate MRIs were significantly less likely to undergo surgery for their condition within 90 days, suggesting that there was less clinical urgency for these latter patients.
  • Using spending data only from the Massachusetts study population, inappropriate imaging for the three conditions was conservatively estimated to have cost commercial insurers from $4.6 to 5.5 million in the two study years. Inappropriate imaging costs would be much higher if computed nationally across all imaging modalities and clinical conditions and if patient cost sharing were considered.

What These Findings Mean

A number of factors may be related to the inappropriate use of diagnostic imaging procedures, including low awareness or use of ACR guidelines among providers, patient beliefs that all imaging is beneficial, defensive medicine, high levels of imaging capacity and financial incentives facing providers. Initiatives that may address some of these factors include pre-authorization requirements, efforts to improve knowledge and uptake of appropriateness guidelines, and incenting patients to be more judicious consumers by increasing their cost sharing. More research is needed to understand the drivers of inappropriate imaging as well as the extent to which proposed solutions will be able to trim inappropriate use.

More About This Study

This study used commercial claims data from Massachusetts to assess the appropriateness of MRIs and X-rays provided to healthy adult patients first presenting with uncomplicated low back pain or non-traumatic knee or shoulder pain. Inappropriateness of diagnostic imaging received within 30 and 60 days of the visit was determined by whether or not the care adhered to the imaging guidelines of the American College of Radiology (ACR). The researchers also assessed how frequently patients with MRIs underwent surgery within 90 days. Chi-squared tests were used to compare rates of inappropriate imaging over time and whether follow-up surgery rates differed by whether the MRI was appropriate or not. Costs of inappropriate care were computed net of the costs of care that would have been appropriate.

Full Citation

Flaherty S, Zepeda ED, Mortele K and Young GJ. “Magnitude and Financial Implications of Inappropriate Diagnostic Imaging for Three Common Clinical Conditions.” International Journal for Quality in Health Care, https://doi.org/10.1093/intqhc/mzy248, published January 23, 2019.

For more information about this study, contact Dr. Gary Young at This email address is being protected from spambots. You need JavaScript enabled to view it.
For more information about the NIHCM Foundation Investigator-Initiated Research Grant Program, contact Dr. Julie Schoenman at 202-296-4426.

Learn More

This Research Insights summarizes a study on diagnostic imaging claims for privately insured patients with back, knee and shoulder pain.

Events

June 13, 2019
opioids-2019-webinar-graphic

The final part in our four-part Defying Despair series, this webinar discussed ongoing efforts to increase access to evidence-based treatment for opioid use disorder and guide people on a path to recovery.

May 16, 2019
Alliance-Rx-Patent-Webinar-052019

Manufacturer practices under the current patent system have come under scrutiny for blocking or delaying the entry of generic or biosimilar drugs into the market. During this webinar, panelists explored the relationship between patents, prices and patient access.

In the News

July 2019
Population Health Spotlight
ALZ-panel1-June2019

Grants

Journalism GrantsJournalism Grant Program

We are now accepting letters of inquiry for the 2019-2020 round of grantmaking. The deadline for submissions is July 15, 2019.

Read More


NYTUpshotLogo

Investigator-Initiated Research Grant Program

We are no longer accepting letters of inquiry for the 2019-2020 round of grantmaking. A small number of applicants will be invited to submit a full proposal in September.

Read More

Awards

Winners Named in the 25th Annual Research and Journalism Awards

Winners Announcment 2018 1

Congratulations to all of the winners of the 25th Annual NIHCM Foundation Research and Journalism Awards! The winners and finalists were honored at a banquet in Washington, DC, in May.

Read More